Management of Accidental Abilify (Aripiprazole) Administration
If aripiprazole was given accidentally, immediately assess the dose ingested, patient age, symptoms, and time since ingestion—then contact poison control (1-800-222-1222) or seek emergency care if the patient shows anything beyond mild drowsiness or has ingested threshold-exceeding doses. 1, 2
Immediate Assessment Steps
Determine if emergency department referral is needed based on these criteria:
- Any patient with self-harm intent or malicious administration should go to the emergency department immediately, regardless of dose 2
- Any symptoms beyond mild drowsiness (moderate sedation, inability to arouse with voice/light touch, confusion, tremor, tachycardia, vomiting) warrant emergency department evaluation 2, 3
- Time-sensitive evaluation: If the patient is asymptomatic and more than 6 hours have passed since ingestion, they are unlikely to develop symptoms and can be observed at home with follow-up 2
Dose-Based Thresholds for Home Observation
For children under 12 years old (medication-naïve):
- Can observe at home if dose is less than 15 mg aripiprazole AND experiencing no more than mild drowsiness 2
- Emergency department referral required if dose equals or exceeds 15 mg 2
For patients 12 years and older (medication-naïve):
- Can observe at home if dose is less than 50 mg aripiprazole AND experiencing no more than mild drowsiness 2
- Emergency department referral required if dose equals or exceeds 50 mg 2
For patients on chronic aripiprazole therapy:
- Can observe at home unless they ingested more than 5 times their current single dose 2
Clinical Toxicity Profile
Young children are at highest risk for significant toxicity:
- A 2-year-old who ingested just 10 mg (two 5-mg tablets) developed marked lethargy, tremor, and tachycardia persisting over 72 hours with a drug level of 160 ng/mL at 34 hours post-ingestion 3
- Another 2-year-old ingesting 40 mg experienced vomiting and significant lethargy lasting approximately 30 hours 4
- Adolescents generally tolerate larger doses better, with cases of 120-300 mg producing minimal or transient symptoms 5, 4
Expected symptoms include:
- Lethargy and sedation (most common) 1, 3, 4
- Gastrointestinal upset (vomiting, nausea) 1, 4
- Tremor and extrapyramidal symptoms 3
- Tachycardia 3
- Orthostatic hypotension and dizziness 1
- Confusion 1
Home Observation Protocol
If home observation is appropriate:
- Instruct caregivers to call poison control if symptoms develop or worsen 2
- Poison center should make follow-up calls until at least 6 hours after ingestion if mild drowsiness is present 2
- Do not observe during normal sleep hours—consider emergency department referral if observation would occur when patient or caregiver would normally be sleeping 2
- Monitor for at least 72 hours in young children given prolonged toxicity potential 3
What NOT to Do
- Do not induce emesis 2
- Do not delay transportation to administer activated charcoal if emergency department evaluation is warranted 2
- There is no specific evidence supporting out-of-hospital activated charcoal administration for aripiprazole exposures 2
Emergency Department Transport Considerations
If emergency department evaluation is needed:
- Consider ambulance transport based on patient condition and distance to hospital 2
- Implement continuous cardiac monitoring during transport (conduction disturbances have been reported with atypical antipsychotics) 2
- Provide supportive care including airway management and IV fluids for hypotension 2
Special Warnings from FDA Labeling
Contact healthcare provider immediately if overdose occurs 1:
- Call poison control at 1-800-222-1222 1
- Go to nearest emergency room 1
- Serious risks include neuroleptic malignant syndrome (high fever, stiff muscles, confusion, sweating, pulse/blood pressure changes), uncontrolled body movements, metabolic problems, seizures, and temperature regulation problems 1
Key Clinical Pitfall
The most critical error is underestimating toxicity risk in young children—even small doses (10 mg) can produce prolonged, significant symptoms in toddlers due to aripiprazole's long half-life and higher drug levels achieved in smaller patients 3, 4. When in doubt with pediatric exposures, err on the side of emergency department evaluation.